3.9467
0.25%
-0.0533
Precedente Chiudi:
$4.00
Aprire:
$3.93
Volume 24 ore:
36,142
Relative Volume:
0.34
Capitalizzazione di mercato:
$81.68M
Reddito:
$79.89M
Utile/perdita netta:
$-12.35M
Rapporto P/E:
-4.7551
EPS:
-0.83
Flusso di cassa netto:
$32.92M
1 W Prestazione:
-6.34%
1M Prestazione:
-26.65%
6M Prestazione:
-27.59%
1 anno Prestazione:
-26.11%
Journey Medical Corp Stock (DERM) Company Profile
Nome
Journey Medical Corp
Settore
Telefono
480-434-6670
Indirizzo
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Confronta DERM con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
3.99 | 81.68M | 79.89M | -12.35M | 32.92M | -0.83 |
ZTS
Zoetis Inc
|
164.02 | 73.93B | 9.15B | 2.43B | 2.31B | 5.32 |
HLN
Haleon Plc Adr
|
9.19 | 41.66B | 14.26B | 1.55B | 0 | 0.3383 |
TAK
Takeda Pharmaceutical Co Adr
|
13.08 | 41.52B | 30.27B | 1.93B | 3.45B | 0.6044 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.00 | 23.79B | 16.77B | -959.00M | 1.37B | -0.85 |
VTRS
Viatris Inc
|
11.62 | 13.88B | 15.05B | -883.30M | 1.89B | -0.74 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
2024-06-28 | Ripresa | ROTH MKM | Buy |
2021-12-07 | Iniziato | B. Riley Securities | Buy |
Journey Medical Corp Borsa (DERM) Ultime notizie
DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management - Dermatology Times
LAVA Therapeutics NV (LVTX)’S -5.56% Retreat Makes It Worth Considering Again - Stocks Register
Tillys Inc (TLYS): Major Improvements, Worth A Look - Stocks Register
Journey Medical (NASDAQ:DERM) Shares Down 5.3%Here's Why - MarketBeat
SWK Holdings Provides Portfolio Update - AccessWire
Malaysia’s education, business, healthcare AI journey in 2024 - The Malaysian Reserve
Bridgebio’s Attruby FDA nod boosts stock; 10 November approvals - BioWorld Online
One Man Shares His Journey With ATTR-CM - Health Central
Journey Medical Decline Means Insider Profits Down To US$101k - Simply Wall St
Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short Interest - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Position in Service Properties Trust (NASDAQ:SVC) - Defense World
Walleye Capital LLC Takes $220,000 Position in The Taiwan Fund, Inc. (NYSE:TWN) - Defense World
GE HealthCare - linkedin
Injection Perfection Medical Spa Unveils Morpheus8 OptimasMax for Comprehensive Aesthetic Treatments. - StreetInsider.com
How we help consumers eat well and support their health - Danone
Our mission - Danone
Michelle Borland of Vital Strandz: The Journey to Becoming a Trusted Hair Loss Practitioner for Individuals in the USA - Yahoo Finance
TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Journe - GuruFocus.com
Palmar Hyperhidrosis Pipeline Trends 2024: Clinical Trials, - openPR
Nahdi Medical Company solidifies its position as the largest primary healthcare provider in the Kingdom - ZAWYA
Journey Medical Corp (DERM) Should Be Considered For The Next Few Weeks - Stocks Register
AI Face Reshape Simulator: How It Transforms Med Spa Consultations - Perfect Corp.
One Behavioral Provider’s Decision to Co-Develop Technology - Healthcare Innovation
Women of Influence: Erica Conroy's journey from the lab to the C-SuiteColumbus Business First - The Business Journals
FY2024 EPS Estimate for Journey Medical Decreased by Analyst - MarketBeat
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys - Yahoo Finance
FY2024 EPS Estimates for Journey Medical Boosted by B. Riley - MarketBeat
Showcasing the Journey of Researchers and Entrepreneurs at UP Manila’s Salinlohiya 2024 - University of the Philippines Manila
NY AI medical company wins global health tech competition at Scientific Sessions 2024 - American Heart Association
Journey Medical Co. (NASDAQ:DERM) Short Interest Down 20.7% in October - MarketBeat
Despite Journey Medical's Pullback, Insiders Still Gained US$118k - Yahoo Finance
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance
Topgolf Callaway Q3 Earnings & Revenues Top Estimates, Fall Y/Y - Yahoo Finance
Entero, Journey to merge, creating oncology-focused biopharma - Investing.com
Journey Medical Corp (DERM) Q3 2024 Earnings: Revenue Hits $14.6M, EPS Loss of $0.12 Beats Estimates - GuruFocus.com
Journey Medical earnings beat by $0.05, revenue topped estimates - Investing.com
Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Runway Growth Finance Corp. (RWAY) Q3 Earnings and Revenues Lag Estimates - Yahoo Finance
Earnings Flash (DERM) JOURNEY MEDICAL CORPORATION Reports Q3 Revenue $14.6M - Marketscreener.com
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance
Lost emperor penguin recovering after record journey across Southern Ocean - ABC News
Best travel insurance companies in 2024 - USA TODAY
FY2024 EPS Estimates for Journey Medical Raised by Analyst - MarketBeat
Q3 EPS Estimates for Journey Medical Reduced by Roth Capital - Defense World
FDA approves Journey Medical’s rosacea treatment Emrosi - Yahoo Finance
Journey gets FDA okay for Emrosi, releases preliminary Q3 earnings report (NASDAQ:DERM) - Seeking Alpha
US FDA approves Journey Medical's drug for long-term skin condition - Reuters
Journey Medical gains as US FDA approves skin condition drug - XM
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - Yahoo Finance
mWell says users gain access to 26 MPH hospitals - BusinessWorld Online
Journey Medical Corp Azioni (DERM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):